Gene therapy via CRISPR/Cas9-mediated Cxcr4 disease allele inactivation reverses leukopenia in WHIM mice
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci202073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Ji-Liang Gao und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Receptors, CXCR4, Leukopenia, Genetic Therapy, CRISPR-Cas Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Gao, J. L., Li, Z., Calderon-Perez, R., Pavek, A., Kim, L., McDermott, D. H., & Murphy, P. M. (2026). Gene therapy via CRISPR/Cas9-mediated Cxcr4 disease allele inactivation reverses leukopenia in WHIM mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci202073
Vancouver
Gao JL, Li Z, Calderon-Perez R, Pavek A, Kim L, McDermott DH, et al. Gene therapy via CRISPR/Cas9-mediated Cxcr4 disease allele inactivation reverses leukopenia in WHIM mice. Journal of Clinical Investigation. 2026. doi:10.1172/jci202073
BibTeX
@article{Gao2026,
author = {Gao, Ji-Liang and Li, Zhanzhuo and Calderon-Perez, Rafael and Pavek, Antonia and Kim, Lina and McDermott, David H and Murphy, Philip M},
title = {Gene therapy via CRISPR/Cas9-mediated Cxcr4 disease allele inactivation reverses leukopenia in WHIM mice},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci202073}
}
EUVIMED